Intraperitoneal chemotherapy in the treatment of advanced ovarian cancer

被引:3
|
作者
Classe, J. -M. [1 ]
Muller, M. [2 ]
Frenel, J. -S. [3 ]
Rigaud, D. Berton [3 ]
Ferron, G. [4 ]
Jaffre, I. [1 ]
Gladieff, L. [5 ]
机构
[1] Ctr Rene Gauducheau, Dept Chirurg Oncol, F-44805 St Herblain, France
[2] CHU Nantes, Dept Chirurg Oncol, F-44 Nantes, France
[3] Ctr Rene Gauducheau, Dept Med Oncol, F-44805 St Herblain, France
[4] Inst Claudius Regaud, Dept Chirurg Oncol, Toulouse, France
[5] Inst Claudius Regaud, Dept Med Oncol, Toulouse, France
关键词
Advanced ovarian cancer; Intraperitoneal chemotherapy; Hyperthermic intraperitoneal chemotherapy; HYPERTHERMIC PERITONEAL PERFUSION; HIGH-DOSE CARBOPLATIN; CYTOREDUCTIVE SURGERY; COMPLETE RESECTION; CARCINOMA PATIENTS; PHASE-II; CISPLATIN; RECURRENT; THERAPY; PACLITAXEL;
D O I
10.1016/j.jgyn.2009.12.007
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The standard treatment for advanced ovarian cancer consist in complete surgical debulking and intravenous platin and taxane based chemotherapy. Despite research efforts, a lot of patients still die from peritoneal carcinomatosis. The aim of our work was to present the state of art about intraperitoneal chemotherapy. Intraperitoneal chemotherapy (IPC): three multi-institutional randomised trials showed that platin based IPC gave better results in term of overall and disease free survival when compared to standard intravenous treatment. Even so, IPC is not yet becoming a new international standard of treatment because a high rate of morbidity. Hyperthermic Intraperitoneal chemotherapy (HIPEC) represents an innovative alternative to IPC. HIPEC is based on a complete surgical debulking without any visible mass and an intraperitoneal chemotherapy with synergy of hyperthermia. Phase II trails have shown its feasibility. Randomised trials are needed to assess its efficiency in improving survival. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:183 / 190
页数:8
相关论文
共 50 条
  • [31] Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: Old and Novel Questions
    Tomao, Federica
    Panici, Pierluigi Benedetti
    Tomao, Silverio
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (33) : 3168 - +
  • [32] Intraperitoneal chemotherapy for advanced epithelial ovarian cancer: a Canadian perspective
    Alhayki, M.
    Hopkins, L.
    Le, T.
    Fung, M. Fung Kee
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (05) : 1761 - 1765
  • [33] Intraperitoneal chemotherapy in patients with advanced ovarian cancer: The con view
    Vergote, Ignace
    Amant, Frederic
    Leunen, Karin
    Cadron, Isabelle
    Van Gorp, Toon
    Neven, Patrick
    Berteloot, Patrick
    ONCOLOGIST, 2008, 13 (04): : 410 - 414
  • [34] Vaginal evisceration during intraperitoneal chemotherapy for advanced ovarian cancer
    Burkett, Amy M.
    Cohn, David E.
    Copeland, Larry J.
    GYNECOLOGIC ONCOLOGY, 2007, 104 (02) : 491 - 493
  • [35] Hyperthermic Intraperitoneal Chemotherapy as a Treatment for Epithelial Ovarian Cancer
    Fahim, Mohamed Ibrahim
    Nassar, Omaya Abdelhamid
    Mansour, Osman Mohamed
    Ali, Abdelmaksoud Mohamed
    Mahmoud, Ahmed-Mostafa
    Hafez, Nesreen Hassan
    Allam, Rasha Mahmoud
    Kamal, Amr
    Ghareeb, Mohamed
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2019, 10 (03) : 417 - 421
  • [36] Hyperthermic Intraperitoneal Chemotherapy as a Treatment for Epithelial Ovarian Cancer
    Mohamed Ibrahim Fahim
    Omaya Abdelhamid Nassar
    Osman Mohamed Mansour
    Abdelmaksoud Mohamed Ali
    Ahmed-Mostafa Mahmoud
    Nesreen Hassan Hafez
    Rasha Mahmoud Allam
    Amr Kamal
    Mohamed Ghareeb
    Indian Journal of Surgical Oncology, 2019, 10 : 417 - 421
  • [37] Intraperitoneal Chemotherapy A Reemerging Approach in the Treatment of Ovarian Cancer
    Drake, Barbie
    JOURNAL OF INFUSION NURSING, 2009, 32 (06) : 314 - 322
  • [38] Pharmacologic principles of intraperitoneal chemotherapy for the treatment of ovarian cancer
    Howell, S. B.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 : 20 - 25
  • [39] Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer
    Wright, Alexi A.
    Cronin, Angel
    Milne, Dana E.
    Bookman, Michael A.
    Burger, Robert A.
    Cohn, David E.
    Cristea, Mihaela C.
    Griggs, Jennifer J.
    Keating, Nancy L.
    Levenback, Charles F.
    Mantia-Smaldone, Gina
    Matulonis, Ursula A.
    Meyer, Larissa A.
    Niland, Joyce C.
    Weeks, Jane C.
    O'Malley, David M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (26) : 2841 - +
  • [40] Intraperitoneal Chemotherapy: An Important Strategy in Ovarian Cancer Treatment
    Muggia, Franco M.
    PLATINUM AND OTHER HEAVY METAL COMPOUNDS IN CANCER CHEMOTHERAPY: MOLECULAR MECHANISMS AND CLINICAL APPLICATIONS, 2009, : 329 - 333